Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience

Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study

(2010) J. Martin-Broto et al.   ANNALS OF ONCOLOGY

Tyrosine kinase mutations in gastrointestinal stromal tumors in a nation-wide study in Iceland

(2010) GEIR TRYGGVASON et al.   APMIS

Implications of Mutational Analysis for the Management of Patients With Gastrointestinal Stromal Tumors and the Application of Targeted Therapies

(2010) Agnieszka Wozniak et al.   CANCER INVESTIGATION

Microscopic Gastrointestinal Stromal Tumors in Esophageal and Intestinal Surgical Resection Specimens

(2009) Abbas Agaimy et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Clinical significance of oncogenicKITandPDGFRAmutations in gastrointestinal stromal tumours

(2008) J Lasota et al.   HISTOPATHOLOGY

Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group

(2008) Michael C. Heinrich et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases

(2008) Jerzy Lasota et al.   MODERN PATHOLOGY